These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 36813921)
1. The deubiquitinating enzyme UCHL3 promotes anaplastic thyroid cancer progression and metastasis through Hippo signaling pathway. Tang J; Yang Q; Mao C; Xiao D; Liu S; Xiao L; Zhou L; Wu G; Tao Y Cell Death Differ; 2023 May; 30(5):1247-1259. PubMed ID: 36813921 [TBL] [Abstract][Full Text] [Related]
2. SOX13/TRIM11/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer. Tang J; Tian Z; Liao X; Wu G Int J Biol Sci; 2021; 17(2):417-429. PubMed ID: 33613102 [TBL] [Abstract][Full Text] [Related]
3. UBR1 promotes anaplastic thyroid carcinoma progression via stabilizing YAP through monoubiquitylation. Xia M; Liang C; Yuan Y; Luo J; Zeng Y; Zhang M; Tang J; Jiang Z; Gong Y; Xie C Sci Rep; 2024 Aug; 14(1):19496. PubMed ID: 39174635 [TBL] [Abstract][Full Text] [Related]
4. USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ. Tang J; Luo Y; Xiao L Cell Death Dis; 2022 Apr; 13(4):326. PubMed ID: 35397626 [TBL] [Abstract][Full Text] [Related]
5. The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor. Ouyang L; Yan B; Liu Y; Mao C; Wang M; Liu N; Wang Z; Liu S; Shi Y; Chen L; Wang X; Cheng Y; Cao Y; Xiao D; Zhang L; Liu S; Tao Y Signal Transduct Target Ther; 2020 Jun; 5(1):78. PubMed ID: 32546741 [TBL] [Abstract][Full Text] [Related]
6. ATXN3 promotes prostate cancer progression by stabilizing YAP. Wu L; Ou Z; Liu P; Zhao C; Tong S; Wang R; Li Y; Yuan J; Chen M; Fan B; Zu X; Wang Y; Tang J Cell Commun Signal; 2023 Jun; 21(1):152. PubMed ID: 37349820 [TBL] [Abstract][Full Text] [Related]
7. USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP. Zhang W; Luo J; Xiao Z; Zang Y; Li X; Zhou Y; Zhou J; Tian Z; Zhu J; Zhao X Cell Death Dis; 2022 Dec; 13(12):1021. PubMed ID: 36470870 [TBL] [Abstract][Full Text] [Related]
8. MINDY1 promotes bladder cancer progression by stabilizing YAP. Luo Y; Zhou J; Tang J; Zhou F; He Z; Liu T; Liu T Cancer Cell Int; 2021 Jul; 21(1):395. PubMed ID: 34315490 [TBL] [Abstract][Full Text] [Related]
9. YAP-VGLL4 antagonism defines the major physiological function of the Hippo signaling effector YAP. Cai J; Choi K; Li H; Pulgar Prieto KD; Zheng Y; Pan D Genes Dev; 2022 Nov-Dec 1; 36(21-24):1119-1128. PubMed ID: 36522128 [TBL] [Abstract][Full Text] [Related]
10. UCHL3 promotes ovarian cancer progression by stabilizing TRAF2 to activate the NF-κB pathway. Zhang MH; Zhang HH; Du XH; Gao J; Li C; Shi HR; Li SZ Oncogene; 2020 Jan; 39(2):322-333. PubMed ID: 31477831 [TBL] [Abstract][Full Text] [Related]
11. Ubiquitin carboxyl-terminal hydrolase l3 promotes insulin signaling and adipogenesis. Suzuki M; Setsuie R; Wada K Endocrinology; 2009 Dec; 150(12):5230-9. PubMed ID: 19837878 [TBL] [Abstract][Full Text] [Related]
12. UCHL3 inhibits ferroptosis by stabilizing β-catenin and maintains stem-like properties of hepatocellular carcinoma cells. Long G; Wu Z; Wang D; Mi X; Hu K; Zhou L; Tang J Free Radic Biol Med; 2024 Feb; 212():162-173. PubMed ID: 38092274 [TBL] [Abstract][Full Text] [Related]
13. UCHL3 promotes hepatocellular carcinoma progression by stabilizing EEF1A1 through deubiquitination. Zhao J; Huo Q; Zhang J; Sun K; Guo J; Cheng F; Hu X; Xu Q Biol Direct; 2024 Jul; 19(1):53. PubMed ID: 38965582 [TBL] [Abstract][Full Text] [Related]
14. OTUD6A orchestrates complex modulation of TEAD4-mediated transcriptional programs. Kim HJ; Choi Y; Lee Y; Hwangbo M; Kim J FEBS Lett; 2024 May; 598(9):1045-1060. PubMed ID: 38594215 [TBL] [Abstract][Full Text] [Related]
15. Tea domain transcription factor TEAD4 mitigates TGF-β signaling and hepatocellular carcinoma progression independently of YAP. Luo W; Li Y; Zeng Y; Li Y; Cheng M; Zhang C; Li F; Wu Y; Huang C; Yang X; Kremerskothen J; Zhang J; Zhang C; Tu S; Li Z; Luo Z; Lin Z; Yan X J Mol Cell Biol; 2023 Jun; 15(2):. PubMed ID: 36806855 [TBL] [Abstract][Full Text] [Related]
16. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis. Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750 [TBL] [Abstract][Full Text] [Related]
17. UCHL3 promotes cervical cancer development and metastasis by stabilizing NRF2 via deubiquitination. Zhang Y; Liu JB; Liu J; Liu M; Liu HL; Zhang J Biochem Biophys Res Commun; 2023 Jan; 641():132-138. PubMed ID: 36527747 [TBL] [Abstract][Full Text] [Related]
18. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells. Van Sciver N; Ohashi M; Pauly NP; Bristol JA; Nelson SE; Johannsen EC; Kenney SC PLoS Pathog; 2021 Aug; 17(8):e1009783. PubMed ID: 34339458 [TBL] [Abstract][Full Text] [Related]
19. CK2-induced cooperation of HHEX with the YAP-TEAD4 complex promotes colorectal tumorigenesis. Guo Y; Zhu Z; Huang Z; Cui L; Yu W; Hong W; Zhou Z; Du P; Liu CY Nat Commun; 2022 Aug; 13(1):4995. PubMed ID: 36008411 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of UCHL3 inhibits esophageal squamous cell carcinoma progression by reducing CRY2 methylation. Xue J; Yi J; Zhu X Hum Cell; 2022 Mar; 35(2):528-541. PubMed ID: 35088238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]